1500005I dynport vaccine company
Ended Awarded Last action
- Contract number
- 75N93020F00001
- Awardee
-
Dynport Vaccine Company LLC UEI LXNEGTYDR755
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $120,437
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2013178 Solicitation number
- Contract value 100% obligated
- $120,437.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$8,881 | |
| Funding Only Action | -$352 | |
| Supplemental Agreement for work within scope | $8,881 | |
| Original award | $120,789 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Dynport Vaccine Company LLC on December 15, 2019, under the Therapeutics Against Infectious Diseases Phase 1 parent IDIQ with a ceiling value of $120,437.29 for a Phase 1 clinical trial unit supporting therapeutics against infectious diseases.
Place of performance is Frederick, MD. The order is priced on a cost-plus-fixed-fee basis and has an ultimate completion date of December 14, 2020. Dynport, a General Dynamics subsidiary, provides research, development, manufacturing, and testing services for biopharmaceutical products targeting infectious diseases, with past federal work in preclinical development, clinical trials, diagnostic testing, vaccine stability evaluations, and cGMP production.
Quick answers
Who was awarded contract 75N93020F00001?
75N93020F00001 was awarded to Dynport Vaccine Company LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 15, 2019.
How much is contract 75N93020F00001 worth?
The government has obligated $120,437 on 75N93020F00001.
Is contract 75N93020F00001 an order under another contract?
Yes. 75N93020F00001 is a delivery order under HHSN272201500005I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.
Was contract 75N93020F00001 competed?
The extent of competition for 75N93020F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award